National Vaccine
Information Center

Your Health. Your Family. Your Choice.

MedAlerts.org
Search Results

From the 1/7/2022 release of VAERS data:

Found 21,745 cases where Vaccine targets COVID-19 (COVID19) and Patient Died

Government Disclaimer on use of this data



Case Details

This is page 1263 out of 2,175

Result pages: prev   1254 1255 1256 1257 1258 1259 1260 1261 1262 1263 1264 1265 1266 1267 1268 1269 1270 1271 1272   next


VAERS ID: 1234385 (history)  
Form: Version 2.0  
Age:   
Sex: Female  
Location: Foreign  
Vaccinated:2021-02-11
Onset:2021-02-28
   Days after vaccination:17
Submitted: 0000-00-00
Entered: 2021-04-20
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
COVID19: COVID19 (COVID19 (PFIZER-BIONTECH)) / PFIZER/BIONTECH EJ6789 / 2 LA / OT

Administered by: Other       Purchased by: ?
Symptoms: Coma, Ischaemic stroke
SMQs:, Hyperglycaemia/new onset diabetes mellitus (broad), Neuroleptic malignant syndrome (broad), Ischaemic central nervous system vascular conditions (narrow), Embolic and thrombotic events, arterial (narrow), Noninfectious encephalitis (broad), Noninfectious encephalopathy/delirium (broad), Noninfectious meningitis (broad), Hypoglycaemia (broad)

Life Threatening? No
Birth Defect? No
Died? Yes
   Date died: 2021-03-03
   Days after onset: 3
Permanent Disability? No
Recovered? No
Office Visit? No
ER Visit? No
ER or Doctor Visit? No
Hospitalized? Yes, ? days
   Extended hospital stay? No
Previous Vaccinations:
Other Medications:
Current Illness: Arterial hypertension; Dyslipidaemia; Mitral incompetence
Preexisting Conditions:
Allergies:
Diagnostic Lab Data:
CDC Split Type: FRPFIZER INC2021409397

Write-up: coma; Ischemic stroke; This is a spontaneous report from a contactable physician downloaded from the Agency Regulatory Authority-WEB FR-AFSSAPS-PA20210451. A 92-years-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), dose 2 intramuscular, administered in Arm Left on 11Feb2021 (Lot Number: EJ6789) at single dose (0.3ml) for covid-19 immunisation. Medical history included ongoing dyslipidaemia , ongoing Arterial hypertension, ongoing Mitral incompetence. The patient previously administrated the first dose of BNT162B2 for covid-19 immunisation on unknown date. The patient''s concomitant medications were not reported. The patient experienced ischemic stroke on 28Feb2021, coma on 28Feb2021 lead to hospitalization on an unspecified date with outcome of unknown. The patient died of Ischemic stroke on 03Mar2021. It was not reported if an autopsy was performed. No follow-up attempts are possible, batch number already obtained.; Reported Cause(s) of Death: Ischemic stroke


VAERS ID: 1234389 (history)  
Form: Version 2.0  
Age:   
Sex: Female  
Location: Foreign  
Vaccinated:2021-03-23
Onset:2021-03-27
   Days after vaccination:4
Submitted: 0000-00-00
Entered: 2021-04-20
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
COVID19: COVID19 (COVID19 (PFIZER-BIONTECH)) / PFIZER/BIONTECH ER9470 / 1 - / OT

Administered by: Other       Purchased by: ?
Symptoms: Condition aggravated, Dyspnoea, Fatigue, Oxygen saturation, Oxygen saturation decreased, Progressive supranuclear palsy, Pyrexia, SARS-CoV-2 test
SMQs:, Anaphylactic reaction (broad), Neuroleptic malignant syndrome (broad), Anticholinergic syndrome (broad), Dementia (narrow), Acute central respiratory depression (broad), Pulmonary hypertension (broad), Cardiomyopathy (broad), Respiratory failure (broad), Drug reaction with eosinophilia and systemic symptoms syndrome (broad), Infective pneumonia (broad), COVID-19 (broad)

Life Threatening? No
Birth Defect? No
Died? Yes
   Date died: 2021-04-01
   Days after onset: 5
Permanent Disability? No
Recovered? No
Office Visit? No
ER Visit? No
ER or Doctor Visit? Yes
Hospitalized? Yes, ? days
   Extended hospital stay? No
Previous Vaccinations:
Other Medications:
Current Illness: Progressive supranuclear palsy
Preexisting Conditions: Medical History/Concurrent Conditions: Embolism pulmonary; Fractured neck of femur; Septicaemia; Thrombosis
Allergies:
Diagnostic Lab Data: Test Date: 20210331; Test Name: Arterial oxygen saturation; Test Result: 75 %; Test Date: 20210331; Test Name: COVID-19 PCR test; Result Unstructured Data: Test Result:negative
CDC Split Type: FRPFIZER INC2021409466

Write-up: worsening of symptoms of an already existing pathology; worsening of symptoms of an already existing pathology; oxygen saturation: 75 % on 31Mar2021; She experienced worsening of her symptoms 4 days after vaccination, associated with fever, difficulty breathing and fatigue.; She experienced worsening of her symptoms 4 days after vaccination, associated with fever, difficulty breathing and fatigue.; She experienced worsening of her symptoms 4 days after vaccination, associated with fever, difficulty breathing and fatigue.; This is a spontaneous report received from a contactable physician downloaded from the Agency Regulatory Authority-WEB. The regulatory authority report number is FR-AFSSAPS-PB20211982. Safety report unique identifier FR-AFSSAPS-2021035447. A 83-years-old female patient received bnt162b2 (COMIRNATY), dose 1 intramuscular on 23Mar2021 (Lot Number: ER9470) as single dose for covid-19 immunisation. Medical history included pulmonary embolism from 2017 to an unknown date, septicaemia from 2017 to an unknown date, fractured neck of femur from 2019 to an unknown date, progressive supranuclear palsy from 2016 and ongoing, thrombosis from 2017 to an unknown date. The patient''s concomitant medications were not reported. The patient previously took modopar, scopoderm [hyoscine], ELIQUIS. The patient experienced worsening of symptoms of an already existing pathology (progressive supranuclear palsy) associated with fever, difficulty breathing and fatigue, all on 27Mar2021, oxygen saturation: 75 % on 31Mar2021. For event worsening of symptoms of an already existing pathology (progressive supranuclear palsy), the patient was taken into emergency care unit and hospitalized from 31Mar2021 to an unknown date. The patient underwent lab tests and procedures which included oxygen saturation: 75 % on 31Mar2021, COVID-19 PCR test: negative on 31Mar2021. The patient died on 01Apr2021 (1 a.m.). It was not reported if an autopsy was performed. The outcome of the event worsening of symptoms of an already existing pathology (progressive supranuclear palsy) was fatal, the outcome of the other events was unknown. No follow-up attempts possible. No further information expected.; Reported Cause(s) of Death: worsening of symptoms of an already existing pathology (progressive supranuclear palsy); worsening of symptoms of an already existing pathology (progressive supranuclear palsy)


VAERS ID: 1234396 (history)  
Form: Version 2.0  
Age:   
Sex: Female  
Location: Foreign  
Vaccinated:2021-03-04
Onset:2021-03-25
   Days after vaccination:21
Submitted: 0000-00-00
Entered: 2021-04-20
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
COVID19: COVID19 (COVID19 (PFIZER-BIONTECH)) / PFIZER/BIONTECH UNKNOWN / 1 - / OT

Administered by: Other       Purchased by: ?
Symptoms: Decreased appetite, Dyspnoea, Hypoxia, Pulmonary embolism
SMQs:, Anaphylactic reaction (broad), Asthma/bronchospasm (broad), Embolic and thrombotic events, venous (narrow), Acute central respiratory depression (broad), Pulmonary hypertension (broad), Cardiomyopathy (broad), Eosinophilic pneumonia (broad), Respiratory failure (broad), Infective pneumonia (broad)

Life Threatening? No
Birth Defect? No
Died? Yes
   Date died: 2021-04-07
   Days after onset: 13
Permanent Disability? No
Recovered? No
Office Visit? No
ER Visit? No
ER or Doctor Visit? No
Hospitalized? Yes, ? days
   Extended hospital stay? No
Previous Vaccinations:
Other Medications:
Current Illness:
Preexisting Conditions: Medical History/Concurrent Conditions: Arrhythmia NOS; Colorectal adenocarcinoma (Lieberkuhnien carcinoma); Permanent cardiac pacemaker insertion
Allergies:
Diagnostic Lab Data:
CDC Split Type: FRPFIZER INC2021409446

Write-up: Embolism pulmonary; severe hypoxia; Alteration of the general condition with dyspnea and anorexia; Alteration of the general condition with dyspnea and anorexia; This is a spontaneous report received from a contactable physician downloaded from the Agency Regulatory Authority-WEB. The regulatory authority report number is FR-AFSSAPS-RE20211026, Safety report unique identifier FR-AFSSAPS-2021036225. A 94-year-old female patient received bnt162b2 (COMIRNATY), dose 1 intramuscular on 04Mar2021 (Batch/Lot Number: Unknown) as single dose for covid-19 immunisation. Medical history included arrhythmia NOS, rhythmic heart disease with pacemaker, colorectal adenocarcinoma (lieberkuhnien carcinoma). The patient''s concomitant medications were not reported. The patient experienced embolism pulmonary (death, hospitalization) on 01Apr2021, severe hypoxia (death, hospitalization) on 01Apr2021, alteration of the general condition with dyspnea and anorexia (non-serious) on 25Mar2021 with outcome of unknown. On 25Mar2021, patient experienced alteration of the general condition with dyspnea and anorexia. 01Apr2021, she was hospitalization with an assessment of a left pulmonary embolism without cardiac repercussions, with oxygen dependence in front of a severe hypoxia. Implementation of an anti-coagulant treatment at an effective dose. Unfavorable evolution, increase in oxygen dependence. The patient died on 07Apr2021. It was not reported if an autopsy was performed.; Reported Cause(s) of Death: severe hypoxia; Embolism pulmonary


VAERS ID: 1234402 (history)  
Form: Version 2.0  
Age:   
Sex: Female  
Location: Foreign  
Vaccinated:2021-02-03
Onset:2021-02-19
   Days after vaccination:16
Submitted: 0000-00-00
Entered: 2021-04-20
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
COVID19: COVID19 (COVID19 (PFIZER-BIONTECH)) / PFIZER/BIONTECH UNKNOWN / 2 - / OT

Administered by: Other       Purchased by: ?
Symptoms: Auscultation, Blood pressure measurement, Body temperature, COVID-19, Heart rate, Oxygen saturation, Physical examination, SARS-CoV-2 test, Vaccination failure
SMQs:, Lack of efficacy/effect (narrow), Infective pneumonia (broad), Opportunistic infections (broad), COVID-19 (narrow)

Life Threatening? No
Birth Defect? No
Died? Yes
   Date died: 2021-03-26
   Days after onset: 34
Permanent Disability? No
Recovered? No
Office Visit? No
ER Visit? No
ER or Doctor Visit? No
Hospitalized? No
Previous Vaccinations:
Other Medications: MODOPAR; DEROXAT; LEVOTHYROX; KARDEGIC; RAMIPRIL; SERESTA; FUROSEMIDE; TAMSULOSIN
Current Illness: Heart failure (1st outbreak of heart failure with secondary bronchial infection in Dec2016)
Preexisting Conditions: Medical History/Concurrent Conditions: Blindness, one eye (Left eye blindness due to tumor enucleation); Bronchial infection (1st outbreak of heart failure with secondary bronchial infection in Dec2016); Decompensation cardiac (Left ventricular decompensation in Jan2018, then Feb2018, then May2019); Depression NOS; Enucleation of eyeball (tumor enucleation); Extrapyramidal syndrome (Extra pyramidal syndrome without proper Parkinson''s disease); Eye prosthesis user (left eye prosthesis); Hashimoto''s thyroiditis (Hypothyroidism due to Hashimoto''s thyroiditis); Hypothyroidism (Hypothyroidism due to Hashimoto''s thyroiditis); Stroke (without sequelae)
Allergies:
Diagnostic Lab Data: Test Date: 20210219; Test Name: Pulmonary auscultation; Result Unstructured Data: Test Result:crackles; Comments: Pulmonary auscultation in which crackles were found mid-field of ICG.; Test Date: 20210225; Test Name: Pulmonary auscultation; Result Unstructured Data: Test Result:increased crackles; Test Date: 20210226; Test Name: Pulmonary auscultation; Result Unstructured Data: Test Result:intercostal indrawing; Test Date: 20210227; Test Name: Pulmonary auscultation; Result Unstructured Data: Test Result:severe crackles; Test Date: 20210303; Test Name: Pulmonary auscultation; Result Unstructured Data: Test Result:reduction of crackles; Test Date: 20210305; Test Name: Pulmonary auscultation; Result Unstructured Data: Test Result:no polypnea; Test Date: 20210323; Test Name: Pulmonary auscultation; Result Unstructured Data: Test Result:polypnea, crackles; Comments: dry bi-basal, symmetrical crackles, wet cough; Test Date: 20210324; Test Name: Pulmonary auscultation; Result Unstructured Data: Test Result:slight polypnea; Test Date: 20210324; Test Name: blood pressure; Result Unstructured Data: Test Result:70/60 mmHg; Comments: hypotension; Test Date: 20210219; Test Name: body temperature; Result Unstructured Data: Test Result:38.6 Centigrade; Test Date: 20210222; Test Name: body temperature; Result Unstructured Data: Test Result:apyrexia Centigrade; Test Date: 20210224; Test Name: body temperature; Result Unstructured Data: Test Result:39.1 Centigrade; Test Date: 20210225; Test Name: body temperature; Result Unstructured Data: Test Result:39 Centigrade; Test Date: 20210227; Test Name: body temperature; Result Unstructured Data: Test Result:apyrexia Centigrade; Test Date: 20210305; Test Name: body temperature; Result Unstructured Data: Test Result:apyrexia Centigrade; Test Date: 20210323; Test Name: heart rate; Result Unstructured Data: Test Result:tachycardia; Test Date: 20210324; Test Name: heart rate; Result Unstructured Data: Test Result:tachycardia; Test Date: 20210219; Test Name: saturation; Test Result: 97 %; Comments: Oxygen requirement (saturation 97/3L).; Test Date: 20210303; Test Name: saturation; Test Result: 95 %; Comments: Saturation 95 / 5L.; Test Date: 20210323; Test Name: saturation; Test Result: 79 %; Comments: at 11 pm. hemodynamic and respiratory failure with desaturation to 79% under 15L; Test Date: 20210323; Test Name: saturation; Test Result: 84 %; Comments: at 5.30 pm saturation 84 / 2L; Test Date: 20210323; Test Name: saturation; Test Result: 93 %; Comments: Oxygen saturation increased to 93% under 10L.; Test Date: 20210324; Test Name: saturation; Test Result: 89 %; Test Date: 20210226; Test Name: physical examination; Result Unstructured Data: Test Result:cyanosis; Comments: cyanosis of the hands; Test Date: 20210227; Test Name: physical examination; Result Unstructured Data: Test Result:Oedema; Comments: very mild Oedema of the Lower Extremities; Test Date: 20210305; Test Name: physical examination; Result Unstructured Data: Test Result:no cyanosis; Test Date: 20210320; Test Name: physical examination; Result Unstructured Data: Test Result:very anxious; Comments: it was noted that the patient was very anxious; Test Date: 20210322; Test Name: physical examination; Result Unstructured Data: Test Result:very thirsty; Comments: the patient was very thirsty and a wrong route was observed during her hydration; Test Date: 20210323; Test Name: physical examination; Result Unstructured Data: Test Result:Cyanosis; Comments: the patient was still very anxious and dehydrated. Cyanosis. Wrong routes. Aspiration brings back milk-white mucous fluid.; Test Date: 20210219; Test Name: SARS-CoV2 PCR test; Test Result: Positive ; Comments: PCR V1 profile - initial strain
CDC Split Type: FRPFIZER INC2021409440

Write-up: positive COVID-19 test with symptoms; positive COVID-19 test with symptoms; This is a spontaneous report received from a contactable pharmacist downloaded from the Agency Regulatory Authority-WEB. The regulatory authority report number is FR-AFSSAPS-RS20210728, Safety report unique identifier FR-AFSSAPS-2021036243. A 98-year-old female patient received the first dose of BNT162B2 (COMIRNATY), intramuscularly administered in Arm on 13Jan2021 (Batch/Lot Number: unknown) and the second dose of BNT162B2 intramuscularly administered in Arm on 03Feb2021 (Batch/Lot Number: Unknown), both as single dose for COVID-19 immunisation. Medical history included cardiac failure from Dec2016 and ongoing, bronchial infection from Dec2016 to an unknown date, decompensation cardiac from Jan2018 to May2019 (Left ventricular decompensation in Jan2018, then Feb2018, then May2019), Stroke in 2017 without sequelae, depression, Hypothyroidism due to Hashimoto''s thyroiditis, Extra pyramidal syndrome without proper Parkinson''s disease, Left eye blindness due to tumor enucleation, left eye prosthesis. Concomitant medications included benserazide hydrochloride, levodopa (MODOPAR); paroxetine hydrochloride (DEROXAT); levothyroxine sodium (LEVOTHYROX); acetylsalicylate lysine (KARDEGIC); ramipril; oxazepam (SERESTA); furosemide; and tamsulosin. The patient has no history of COVID-19. On 19Feb2021, 16 days after the second dose of BNT162B2 injection, symptoms appeared. The patient complained of body aches. Pulmonary auscultation in which crackles were found mid-field of ICG. Hyperthermia at 38.6 T. Oxygen requirement (saturation 97/3L). SARS-CoV2 PCR positive the same day (PCR V1 profile- initial strain). On 22Feb2021, patient apyretic, reports feeling tired. On 24Feb2021, hyperthermia at 39.1T, headache. On 25Feb2021, hyperthermia at 39 T and increased crackles. On 26Feb2021, intercostal indrawing, cyanosis of the hands. On 27Feb2021, patient apyretic, severe crackles, very mild Oedema of the Lower Extremities.On 03Mar2021, reduction of crackles. Saturation 95/5L. On 05Mar2021, good clinical course with persistence of apyrexia, no polypnea or cyanosis. Subsequently, on 20Mar2021, it was noted that the patient was very anxious. On 22Mar2021, the patient was very thirsty and a wrong route was observed during her hydration. On 23Mar2021, at 5.30 p.m., the patient was still very anxious and dehydrated. Cyanosis, saturation 84/2L, polypnea, wet cough and wrong routes, dry bi-basal, symmetrical crackles. Oxygen saturation increased to 93% under 10L. The patient''s physician declares aspiration brings back milk-white mucous fluid. On 23Mar2021, at 11 p.m., hemodynamic and respiratory failure with desaturation to 79% under 15L. Patient in tachycardia. The patient''s physician declared Doubtful about pulmonary oedema in spite of dehydration and due to rapid installation, auscultation and history. On 24Mar2021, hypotension at 70/60, tachycardia with saturation at 89%, slight polypnea. The patient''s physician suggests cardiorespiratory failure due to hypovolemia. On 24Mar2021, collegial decision to stop the treatment, death of the patient on 26Mar2021 Overall, vaccine failure with a positive PCR 16 days after the second injection of the Comirnaty vaccine, improvement in symptoms of COVID infection on 05Mar2021. Subsequently, deterioration of the general condition with the onset of hemodynamic and respiratory failure on 23Mar2021 in a context of dehydration and possible aspiration. Death of the patient. Therapeutic measures were taken as a result of positive COVID-19 test with symptoms. The patient died on 26Mar2021. An autopsy was not performed. No follow-up attempts possible. No further information expected. Information on lot and batch numbers cannot be obtained.; Reported Cause(s) of Death: positive COVID-19 test with symptoms; Vaccination failure


VAERS ID: 1234831 (history)  
Form: Version 2.0  
Age:   
Sex: Female  
Location: Foreign  
Vaccinated:2021-01-07
Onset:2021-01-08
   Days after vaccination:1
Submitted: 0000-00-00
Entered: 2021-04-20
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
COVID19: COVID19 (COVID19 (PFIZER-BIONTECH)) / PFIZER/BIONTECH EL0141 / 2 - / -

Administered by: Other       Purchased by: ?
Symptoms: Acute disseminated encephalomyelitis, Aphasia, Confusional state, Disorientation, Encephalitis, Headache, Hemiplegia, Illness, Investigation, SARS-CoV-2 test, Seizure, Tumefactive multiple sclerosis
SMQs:, Neuroleptic malignant syndrome (broad), Systemic lupus erythematosus (broad), Anticholinergic syndrome (broad), Dementia (broad), Convulsions (narrow), Embolic and thrombotic events, vessel type unspecified and mixed arterial and venous (narrow), Guillain-Barre syndrome (broad), Noninfectious encephalitis (narrow), Noninfectious encephalopathy/delirium (broad), Noninfectious meningitis (broad), Demyelination (narrow), Conditions associated with central nervous system haemorrhages and cerebrovascular accidents (narrow), Generalised convulsive seizures following immunisation (narrow), Drug reaction with eosinophilia and systemic symptoms syndrome (broad), Hypoglycaemia (broad), Dehydration (broad), Immune-mediated/autoimmune disorders (narrow), COVID-19 (broad)

Life Threatening? No
Birth Defect? No
Died? Yes
   Date died: 2021-04-03
   Days after onset: 84
Permanent Disability? No
Recovered? No
Office Visit? No
ER Visit? No
ER or Doctor Visit? No
Hospitalized? Yes, ? days
   Extended hospital stay? No
Previous Vaccinations:
Other Medications:
Current Illness:
Preexisting Conditions: Medical History/Concurrent Conditions: Depression; Umbilical cord abnormality
Allergies:
Diagnostic Lab Data: Test Name: investigations; Result Unstructured Data: Test Result:infection and inflammation of the brain; Comments: infection and inflammation of the brain was diagnosed; Test Name: COVID-19 virus test; Result Unstructured Data: Test Result:No - Negative COVID-19 test
CDC Split Type: GBPFIZER INC2021405174

Write-up: became ill; infection and inflammation of the brain; Acute disseminated encephalomyelitis; Tumefactive multiple sclerosis; uncontrollable seizures; movement down one side; quickly lost her speech; disoriented; extremely confused; Frequent headaches; This is a spontaneous report from a contactable other healthcare professional received from a Regulatory Agency (RA); the Regulatory Authority report number is GB-MHRA-WEBCOVID-202104080817517910. A 35-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE); Dose 2 via an unspecified route of administration on 07Jan2021 (batch/lot number: EL0141) as a SINGLE DOSE for COVID-19 vaccination. The patient''s medical history included umbilical cord abnormality and depression, both from an unknown date. Patient had no medical history of MS or Encephalitis and had no health issues (as reported). The patient was not enrolled in clinical trial. Patient was not pregnant. Patient has not had symptoms associated with COVID-19. At the start of 2021, patient was a wife and mum of two young boys with everything to live for: working as a dedicated nurse in care homes for over a decade; she worked tirelessly throughout the pandemic. Concomitant medications included anti depression tablet from an unspecified date in 2021 for 3 months.The patient previously received the first dose of BNT162B2 via an unspecified route of administration on 15Dec2020 (batch/lot number: EJ055) as single dose for COVID-19 vaccination.The patient has not tested positive for COVID-19 since having the vaccine; patient tested no - negative for COVID-19 virus test on an unspecified date. The patient experienced frequent headaches on 08Jan2021; tumefactive multiple sclerosis on 16Feb2021 (described as "very, very, very rare aggressive form of MS"); acute disseminated encephalomyelitis on 17Feb2021; and became ill (Illness) on Feb2021. On an unspecified date, the patient also experienced infection and inflammation of the brain (Encephalitis infection), quickly lost her speech (speech loss), movement down one side (paralysis one side of body), disoriented (disorientated), extremely confused (confused), and uncontrollable seizures (seizures). The patient was hospitalized for 46 days due to tumefactive multiple sclerosis, acute disseminated encephalomyelitis, and infection and inflammation of the brain. Event "became ill" caused hospitalization. Therapeutic measures were taken as a result of tumefactive multiple sclerosis, acute disseminated encephalomyelitis, became ill, infection and inflammation of the brain, and uncontrollable seizures. It was reported that in mid Feb2021, the patient suddenly became ill and was taken into hospital 1 with symptoms of a stroke. After lots of investigations and tests, a stroke was ruled out and an infection and inflammation of the brain was diagnosed on an unspecified date. Unsure of the cause, doctors treated her with steroid medications, none of which seemed to help. After a long wait at hospital 1 she was transferred to hospital 2 where she was assessed by specialists. The family was told that the patient had developed acute disseminated encephalomyelitis (ADEM) on 17Feb2021. ADEM is a rare inflammatory condition that affects the brain and spinal cord. This is the result of the immune system becoming mis-programmed and activating immune cells to attack the healthy myelin cells covering the nerves. Patient quickly lost her speech, movement down one side, and was disoriented, and extremely confused. She was given Plasmapheresis, a plasma exchange treatment to replace her white blood cells and give her immune system a chance to fight back. After weeks of being all alone in the hospital and unable to have her family by her side, she took a turn for the worse. The plasma exchange had not been successful. Her condition was still deteriorating, and she began having uncontrollable seizures. The patient was put into a medically induced coma and was started on a new treatment for Multiple Sclerosis (MS). She spent 2 weeks in Intensive Care on a ventilator. On Wednesday 24Mar2021, the family were told that the patient had developed a very, very, very rare aggressive form of MS and that nothing more could be done to help her. The patient spent a total of 46 days in hospital. On 03Apr2021, the patient passed away peacefully with her husband and her mum by her side. The patient died of tumefactive multiple sclerosis. It was not reported if an autopsy was performed. This report does not relate to possible blood clots or low platelet counts. Follow-up attempts are completed. No further information is expected; Reported Cause(s) of Death: Tumefactive multiple sclerosis


VAERS ID: 1234846 (history)  
Form: Version 2.0  
Age: 82.0  
Sex: Male  
Location: Foreign  
Vaccinated:2021-03-25
Onset:2021-03-25
   Days after vaccination:0
Submitted: 0000-00-00
Entered: 2021-04-20
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
COVID19: COVID19 (COVID19 (PFIZER-BIONTECH)) / PFIZER/BIONTECH - / 2 - / -

Administered by: Other       Purchased by: ?
Symptoms: Coma scale, Haemorrhage intracranial, Inappropriate schedule of product administration, Off label use, SARS-CoV-2 test, Subarachnoid haemorrhage
SMQs:, Haemorrhage terms (excl laboratory terms) (narrow), Haemorrhagic central nervous system vascular conditions (narrow), Medication errors (narrow), COVID-19 (broad)

Life Threatening? No
Birth Defect? No
Died? Yes
   Date died: 2021-04-11
   Days after onset: 17
Permanent Disability? No
Recovered? No
Office Visit? No
ER Visit? No
ER or Doctor Visit? No
Hospitalized? Yes, ? days
   Extended hospital stay? No
Previous Vaccinations:
Other Medications:
Current Illness:
Preexisting Conditions: Medical History/Concurrent Conditions: Chronic kidney disease; Hypertension
Allergies:
Diagnostic Lab Data: Test Date: 202104; Test Name: Glasgow coma scale; Result Unstructured Data: Test Result:decreased; Test Name: COVID-19 virus test; Test Result: Inconclusive ; Comments: Inconclusive test
CDC Split Type: GBPFIZER INC2021411152

Write-up: hemorrhage; Intracranial hemorrhage; first dose BNT162B2 on 14Jan2021/ second dose on 25Mar2021; first dose BNT162B2 on 14Jan2021/ second dose on 25Mar2021; This is a spontaneous report from a contactable pharmacist received from the Agency Regulatory Authority. The regulatory authority report number is GB-MHRA-WEBCOVID-202104120936221340. An 82-year-old male patient received the second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE) via unspecified route of administration on 25Mar2021 (lot number was not known) as a single dose for COVID-19 immunisation. Medical history included hypertension and chronic kidney disease, both from an unknown date and unknown if ongoing. It was unsure if the patient has had symptoms associated with COVID-19 and unsure if the patient was enrolled in clinical trial. Concomitant medications were not reported. The patient had the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE ) on 14Jan2021 for COVID-19 immunisation. The patient was admitted to intensive treatment unit on Apr2021- subarrachnoid haemorrhage (hemorrhage) on 11Apr2021 in which was fatal. It was also noted that intracranial hemorrhage on Apr2021 with decreased Glasgow coma scale suddenly 2 weeks after 2nd dose; this event was reported as not recovered. Additional lab data included COVID-19 virus test: inconclusive test on unspecified date. The patient died on 11Apr2021 due to subarrachnoid haemorrhage. It was unknown if an autopsy was performed. It was unclear if related to vaccine. No follow-up attempts are possible; information about the lot/batch number cannot be obtained.; Reported Cause(s) of Death: Subarachnoid haemorrhage


VAERS ID: 1234856 (history)  
Form: Version 2.0  
Age:   
Sex: Male  
Location: Foreign  
Vaccinated:2021-03-22
Onset:2021-03-24
   Days after vaccination:2
Submitted: 0000-00-00
Entered: 2021-04-20
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
COVID19: COVID19 (COVID19 (PFIZER-BIONTECH)) / PFIZER/BIONTECH ER1749 / 2 - / -

Administered by: Other       Purchased by: ?
Symptoms: Activated partial thromboplastin time, Activated partial thromboplastin time prolonged, Antibody test, Cardiac arrest, Circulatory collapse, Computerised tomogram, Epistaxis, Fibrin D dimer, Hypertension, Loss of consciousness, Platelet count, Prothrombin time, Pulmonary embolism, SARS-CoV-2 test, Scan
SMQs:, Torsade de pointes/QT prolongation (broad), Anaphylactic reaction (narrow), Haemorrhage terms (excl laboratory terms) (narrow), Haemorrhage laboratory terms (broad), Hyperglycaemia/new onset diabetes mellitus (broad), Neuroleptic malignant syndrome (broad), Anticholinergic syndrome (broad), Arrhythmia related investigations, signs and symptoms (broad), Shock-associated circulatory or cardiac conditions (excl torsade de pointes) (narrow), Torsade de pointes, shock-associated conditions (narrow), Hypovolaemic shock conditions (narrow), Toxic-septic shock conditions (narrow), Anaphylactic/anaphylactoid shock conditions (narrow), Hypoglycaemic and neurogenic shock conditions (narrow), Embolic and thrombotic events, venous (narrow), Acute central respiratory depression (broad), Noninfectious encephalitis (broad), Noninfectious encephalopathy/delirium (broad), Noninfectious meningitis (broad), Hypertension (narrow), Cardiomyopathy (broad), Hypotonic-hyporesponsive episode (broad), Generalised convulsive seizures following immunisation (broad), Hypersensitivity (narrow), Respiratory failure (broad), Hypoglycaemia (broad), COVID-19 (broad)

Life Threatening? Yes
Birth Defect? No
Died? Yes
   Date died: 2021-04-11
   Days after onset: 18
Permanent Disability? No
Recovered? No
Office Visit? No
ER Visit? No
ER or Doctor Visit? No
Hospitalized? Yes, ? days
   Extended hospital stay? No
Previous Vaccinations:
Other Medications:
Current Illness:
Preexisting Conditions: Medical History/Concurrent Conditions: Coagulopathy; DVT (left leg); DVT; Non-smoker
Allergies:
Diagnostic Lab Data: Test Name: activated partial thromboplastin clotting time; Result Unstructured Data: Test Result:180; Test Date: 20210411; Test Name: anti-PF4 antibodies; Result Unstructured Data: Test Result:not identified; Test Date: 20210411; Test Name: CTPA scan; Result Unstructured Data: Test Result:extensive hilar and peripheral PEs; Comments: thromboembolic event was PE; diagnosed; Test Date: 20210411; Test Name: D-dimer; Result Unstructured Data: Test Result:not higher than 4000; Test Date: 20210411; Test Name: platelet count; Result Unstructured Data: Test Result:not less than 150/L to 109/L; Test Date: 20200709; Test Name: Platelet count; Result Unstructured Data: Test Result:248; Test Date: 20210411; Test Name: Platelet count; Result Unstructured Data: Test Result:120; Test Name: PT; Result Unstructured Data: Test Result:64.5; Test Date: 20210411; Test Name: COVID-19 virus test; Result Unstructured Data: Test Result:No - Negative COVID-19 test; Test Name: scans; Result Unstructured Data: Test Result:did not detect a problem
CDC Split Type: GBPFIZER INC2021411038

Write-up: collapsed; unconscious; activated partial thromboplastin clotting time (aPTT) was 180; pulmonary embolus; cardiac arrest; nose bleed; high BP; This is a spontaneous report from a contactable physician. This is a report received from the Agency Regulatory Authority. Regulatory authority report number GB-MHRA-WEBCOVID-202104121335362920. A 64-year-old male patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection), dose 2 via an unspecified route of administration on 22Mar2021 (batch/lot number ER1749 and expiry date not reported) as single dose for covid-19 immunization. Medical history included coagulopathy, deep vein thrombosis (left leg, 3 m DOAC) from Mar2020. The reporter informed that further investigations with hematology team and no problems with coagulation. The patient''s persistent problem with swelling of leg but all scans did not detect a problem. The hematology concluded risk of further DVT very slightly higher due to DVT in Mar2020 and on balance and on discussion not for further prophylactic anticoagulation. The patient additional medical history included DVT from Mar2021 that was related to previous venous or arterial thromboses also experienced. The patient had not had any previous reactions to medications (especially heparin or anticoagulants). The patient did not have confirmed or suspected autoimmune or inflammatory disease, including vasculitis. The patient did not have history of, or current, malignancy. The patient did not currently smoke. The patient has no haemorrhage identified. The patient has no history of, or concurrent, intracranial malignancy. The patient did not have concurrent or recent intracranial infections. The patient had not had recent surgical or medical interventions to the central nervous system (including lumbar puncture). The patient had not had a recent trauma/head injury. The patient has not had symptoms associated with COVID-19 and the physician was unsure if patient was enrolled in clinical trial. The patient''s concomitant medications were not reported. The physician informed that on 24Mar2021, the patient experienced spontaneous nose bleed, high BP and was sent home from work, patient saw GP. On 31Mar2021, the patient went back at work and seemed to be fine. On 09Apr2021, the patient at work seemed to be fine. On 11Apr2021, the patient collapsed suddenly in garden at home; the patient was transferred to hospital in ambulance unconscious. At 09:23 to 11:05, the patient experienced cardiac arrest at hospital (cardiac arrest intermittent but prolonged cycles of CPR). The patient recovered after CPR and thrombolysis but prolonged cardiac arrest. The patient was transferred to intensive care sedated, intubated and mechanical ventilated, kidney machine, medicines to support blood pressure and heart. The patient died 18:55 despite full support. The patient underwent lab tests and procedures which included CTPA scan: showed extensive hilar and peripheral PEs (pulmonary embolus). The physician informed that the thromboembolic event was PE (pulmonary embolus) on 11Apr2021 diagnosed with CTPA scan on 11Apr2021. The platelet count was not less than 150/L to 109/L on 11Apr2021. The D-dimer was not higher than 4000. The anti-PF4 antibodies was not identified. The physician informed that the lowest platelet count after vaccine (usual normal range 150 to 450) was 120 on 11Apr2021 14:36. The last platelet count before vaccine (usual normal range 150 to 450) was 248 on 09Jul2020. The patient''s PT (prothrombin time) was 64.5 (unspecified date). The activated partial thromboplastin clotting time (aPTT) was 180. The physician informed that the events was related to possible blood clots or low platelet counts. The patient also underwent lab tests and procedures which included sars-cov-2 test: no - negative covid-19 test on 11Apr2021. The patient has not tested positive for COVID-19 since having the vaccine. The outcome of the events cardiac arrest, activated partial thromboplastin clotting time (aPTT) was 180 was not recovered, collapsed, unconscious was unknown, nose bleed, high BP was recovering, pulmonary embolus was fatal. The patient died on 11Apr2021 18:55, it was unknown if an autopsy was performed. No follow up attempts are possible. No further information is expected.; Reported Cause(s) of Death: Pulmonary embolus


VAERS ID: 1234877 (history)  
Form: Version 2.0  
Age:   
Sex: Female  
Location: Foreign  
Vaccinated:2020-12-20
Onset:0000-00-00
Submitted: 0000-00-00
Entered: 2021-04-20
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
COVID19: COVID19 (COVID19 (PFIZER-BIONTECH)) / PFIZER/BIONTECH EJ0724 / UNK - / -

Administered by: Other       Purchased by: ?
Symptoms: Deep vein thrombosis, Enuresis, Fibrin D dimer, Investigation, Platelet count, Pulmonary embolism, Sudden death
SMQs:, Torsade de pointes/QT prolongation (broad), Arrhythmia related investigations, signs and symptoms (broad), Embolic and thrombotic events, venous (narrow), Thrombophlebitis (broad), Cardiomyopathy (broad)

Life Threatening? Yes
Birth Defect? No
Died? Yes
   Date died: 2021-01-14
Permanent Disability? No
Recovered? No
Office Visit? No
ER Visit? No
ER or Doctor Visit? No
Hospitalized? No
Previous Vaccinations:
Other Medications: CITALOPRAM
Current Illness:
Preexisting Conditions: Medical History/Concurrent Conditions: Abstains from recreational drugs; Alcohol use (Wine drinker); Basal cell carcinoma; Blepharoplasty; Breast implant user; Contraception; D & C; Eyelid operation NOS; Lipoma; Liposuction; Smoker (20 cigarettes'' a day)
Allergies:
Diagnostic Lab Data: Test Name: D-dimer; Result Unstructured Data: Test Result:Unknown; Test Name: anti-PF4 antibodies; Result Unstructured Data: Test Result:Unknown; Test Name: Platelet count; Result Unstructured Data: Test Result:Unknown
CDC Split Type: GBPFIZER INC2021410797

Write-up: Sudden death; acute pulmonary embolism; bed cold; DVT; This is a spontaneous report from a contactable other healthcare professional. This is a report received from the Agency Regulatory Authority. Regulatory authority report number GB-MHRA-WEBCOVID-202104131438452890, Safety Report Unique Identifier GB-MHRA-ADR 25132819. A 58-year-old female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, lot number: EJ0724, expiration date were not reported), via an unspecified route of administration on 20Dec2020 at single dose for covid-19 immunisation. Medical history included other repair of eyelid in 13Jan2014, liposuction of subcutaneous tissue NEC in 04Apr2013, lipoma of other specified sites in 10Feb2013, blepharoplasty of upper eyelid in 24Sep2012, breast augmentation in 24Sep2012, basal cell carcinoma in 20Feb2012, contraception in 2005, dilation of cervix uteri and curettage of uterus in 1983, smoker (20 cigarettes'' a day), drinker (wine drinker). Unsure if patient has had symptoms associated with COVID-19. Not had a COVID-19 test. Unsure if patient is enrolled in clinical trial. Concomitant medication included citalopram. The patient experienced bed cold, acute pulmonary embolism and sudden death on an unspecified date. The events were reported as serious (Life-threatening and Fatal). It was reported that patient was found in bed cold and unresponsive on an unspecified date. Ambulance were called and attended and deemed CPR to be futile. No medical conditions that family are aware of. She smoked around 20 cigarettes per day. She drank wine but amount was unknown. No recreational drugs that family are aware of. It was reported that the report relate to possible blood clots or low platelet counts. The patient was diagnosed with acute pulmonary embolism due to DVT during post mortem examination. Platelet count, D-dimer and anti-PF4 anitbodies were unknown. The patient died on 14Jan2021. Follow-up attempts are completed. No further information is expected.; Reported Cause(s) of Death: Sudden death; Bed cold; Autopsy-determined Cause(s) of Death: Acute Pulmonary Embolism due to DVT; DVT


VAERS ID: 1234885 (history)  
Form: Version 2.0  
Age:   
Sex: Male  
Location: Foreign  
Vaccinated:2021-01-28
Onset:2021-02-01
   Days after vaccination:4
Submitted: 0000-00-00
Entered: 2021-04-20
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
COVID19: COVID19 (COVID19 (PFIZER-BIONTECH)) / PFIZER/BIONTECH EN3924 / 1 - / -

Administered by: Other       Purchased by: ?
Symptoms: Arthralgia, Chest pain, Death, Deep vein thrombosis
SMQs:, Embolic and thrombotic events, venous (narrow), Thrombophlebitis (broad), Gastrointestinal nonspecific symptoms and therapeutic procedures (broad), Cardiomyopathy (broad), Arthritis (broad)

Life Threatening? Yes
Birth Defect? No
Died? Yes
   Date died: 0000-00-00
Permanent Disability? No
Recovered? No
Office Visit? No
ER Visit? No
ER or Doctor Visit? No
Hospitalized? No
Previous Vaccinations:
Other Medications:
Current Illness:
Preexisting Conditions: Medical History/Concurrent Conditions: Ex-smoker (from teens heavy smoker when younger, stopped 20+ years ago.)
Allergies:
Diagnostic Lab Data:
CDC Split Type: GBPFIZER INC2021410987

Write-up: hip pain; dvt; chest pains; Death; This is a spontaneous report from a contactable healthcare professional received from the Agency Regulatory Authority. Regulatory authority report number is GB-MHRA-WEBCOVID-202104131451180500, Safety Report Unique Identifier is GB-MHRA-ADR 25132875. An 81-year-old male patient received first dose of bnt162b2 (COVID-19 MRNA VACCINE BIONTECH), via unspecified route of administration on 28Jan2021 (lot number: EN3924, expiration date not reported), as single dose for COVID-19 immunization. Medical history included ex-tobacco user (from teens heavy smoker when younger, stopped 20+ years ago) and occasional drank whiskey. Concomitant medications were not reported. On an unspecified date in Feb2021, the patient experienced death. On an unspecified date, the patient experienced hip pain, dvt (deep vein thrombosis) and chest pains, all with outcome of unknown. The events hip pain, dvt and chest pains were reported as life-threatening. The patient died on an unspecified date in Feb2021. The clinical course was reported as follows: The patient had been complaining of chest pains over the last couple of days but wasn''t one to bother anyone or go to doctors. On 13Feb2021, he visited his daughter''s address as it was her birthday and seemed fine at that time. At approximately 17:00 hours that day, he was back home and spoke to his son and said he was having chest pains. At 1806 hours, he texted his daughter and it didn''t make sense but this wasn''t unusual. On 14Feb2021 at 10:30 am, a neighbour rang daughter to say that the downstairs blinds were still shut. Family attended home address and found him deceased sat in a chair in the living room. Family confirmed that the patient was mobile on his own using a stick, he would sometimes complain of hip pain if he''d been sat for a while. Patient was an ex-smoker - from teens heavy smoker when younger, stopped 20+ years ago. Alcohol - occasional whiskey. No recreational drug use. No industrial diseases/claims. It was unsure if patient has had symptoms associated with COVID-19. Patient had not had a COVID-19 test. It was unsure if patient was enrolled in clinical trial No follow-up attempts are possible. No further information is expected.; Sender''s Comments: The information provided is limited for reasonable medical assessment. There was no information provided regarding cause of death, autopsy results and diagnostic studies. However, per company causality assessment guidance, the event of death with unknown cause is assessed as related until the cause of death is clarified and re-assessed based on additional data. Queries are in place for the missing information. Other reported events are probably due to an underlying medical condition. This case will be updated once additional information is available.; Reported Cause(s) of Death: Death


VAERS ID: 1234894 (history)  
Form: Version 2.0  
Age:   
Sex: Unknown  
Location: Foreign  
Vaccinated:0000-00-00
Onset:0000-00-00
Submitted: 0000-00-00
Entered: 2021-04-20
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
COVID19: COVID19 (COVID19 (PFIZER-BIONTECH)) / PFIZER/BIONTECH NOT KNOWN / 2 - / -

Administered by: Other       Purchased by: ?
Symptoms: Death
SMQs:

Life Threatening? No
Birth Defect? No
Died? Yes
   Date died: 2021-04-01
Permanent Disability? No
Recovered? No
Office Visit? No
ER Visit? No
ER or Doctor Visit? No
Hospitalized? No
Previous Vaccinations:
Other Medications:
Current Illness:
Preexisting Conditions:
Allergies:
Diagnostic Lab Data:
CDC Split Type: GBPFIZER INC2021411189

Write-up: Death; This is a spontaneous report from a contactable consumer. This is a report received from the Agency Regulatory Authority. Regulatory authority report number: GB-MHRA-WEBCOVID-202104131610048480, Safety Report Unique Identifier: GB-MHRA-ADR 25133023. A patient of unspecified age and gender received BNT162B2, dose 2 via an unspecified route of administration on an unspecified date (Batch/Lot Number: Not Known) as SINGLE DOSE for covid-19 immunization. The patient medical history was not reported. Patient has not had symptoms associated with COVID-19 Patient has not had a COVID-19 test. Patient is not enrolled in clinical trial. Concomitant medications were not reported. The patient died on 01Apr2021. Cause of death was not reported. It was unknown if an autopsy was performed. No follow-up attempts are possible; information about lot/batch number cannot be obtained.; Reported Cause(s) of Death: Death


Result pages: prev   1254 1255 1256 1257 1258 1259 1260 1261 1262 1263 1264 1265 1266 1267 1268 1269 1270 1271 1272   next

New Search

Link To This Search Result:

https://www.medalerts.org/vaersdb/findfield.php?EVENTS=ON&PAGENO=1263&VAX=COVID19&VAXTYPES=COVID-19&DIED=Yes


Copyright © 2022 National Vaccine Information Center. All rights reserved.
21525 Ridgetop Circle, Suite 100, Sterling, VA 20166